Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Aligos Therapeutics Inc (ALGS)

21.54   -2.6 (-10.77%) 03-05 08:48
Open: 24 Pre. Close: 24.14
High: 24.15 Low: 21.19
Volume: 60,382 Market Cap: 821M
Aligos Therapeutics, Inc., a biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a synthetic oligonucleotide that is in Phase I clinical trial for the treatment of chronic hepatitis B (CHB). The company is also developing ALG-000184, a capsid assembly modulator to treat CHB; ALG-020572, a oligonucleotide for the treatment of CHB; ALG-125097, an siRNA drug candidate to treat CHB; and ALG-055009, a small molecule THR-Ã? agonist for the treatment of non-alcoholic steatohepatitis. Aligos Therapeutics, Inc. was founded in 2018 and is headquartered in South San Francisco, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 24.201 - 24.347 24.347 - 24.455
Low: 20.879 - 21.052 21.052 - 21.18
Close: 21.311 - 21.568 21.568 - 21.76

Technical analysis

as of: 2021-03-05 8:06:27 AM
Overall:       
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 34.72     One year: 40.88
Support: Support1: 21.19    Support2: 17.63
Resistance: Resistance1: 29.72    Resistance2: 35.00
Pivot: 27.16
Moving Average: MA(5): 25.68     MA(20): 26.39
MA(100):     MA(250):
MACD: MACD(12,26): -0.67     Signal(9): -0.15
Stochastic oscillator: %K(14,3): 9.91     %D(3): 25.93
RSI: RSI(14): 37.15
52-week: High: 37.51  Low: 12.82  Change(%): 45.1
Average Vol(K): 3-Month: 15821  10-Days: 7148

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
ALGS has closed below the lower band by 1.5%. If price is in a downtrend band; this downward trend in price might continue. However a short term pullback inside the band is likely. Bollinger Bands are 0% narrower than normal.

Headline News

Wed, 03 Mar 2021
Mar 03, 2021 - Novo A Buys Praxis Precision Medicines Inc, Aligos Therapeutics Inc, Eargo Inc, Sells Vanguard Total Stock Market ETF, Medtronic PLC, Catalent Inc - GuruFocus.com

Tue, 16 Feb 2021
Feb 16, 2021 - Logos Global Management LP Buys Olema Pharmaceuticals inc, Nkarta Inc, Kinnate Biopharma Inc, Sells Global Blood Therapeutics Inc, Keros Therapeutics Inc, Sarepta Therapeutics Inc - GuruFocus.com

Sat, 16 Jan 2021
What Is The Ownership Structure Like For Aligos Therapeutics, Inc. (NASDAQ:ALGS)? - Simply Wall St

Thu, 07 Jan 2021
Aligos Therapeutics to Present at the 39th Annual J.P. Morgan Healthcare Conference - GlobeNewswire

Thu, 17 Dec 2020
Aligos Therapeutics Presents Update on Development of SARS-CoV-2 Therapeutic Candidate and Screening Method in Collaboration with KU Leuven at RespiDART & Emerging Viruses 2020 - GlobeNewswire

Mon, 16 Nov 2020
Aligos Therapeutics Presents Data on Chronic Hepatitis B, NASH and Hepatocellular Carcinoma Programs at AASLD's The Liver Meeting Digital Experience™ 2020 - GlobeNewswire

Financial Analysis

Growth NA
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability NA
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency NA
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Underperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Outperform Debt to Equity: Underperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 35
Shares Float (M) 18
% Held by Insiders 15.05
% Held by Institutions 27.47
Shares Short (K) 1,260
Shares Short P. Month (K) 1,450

Stock Financials

EPS
EPS Est This Year
EPS Est Next Year
Book Value (p.s.)
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -2.271
Qtrly Earnings Growth
Operating Cash Flow (M) -70
Levered Free Cash Flow (M)

Stock Valuations

PE Ratio
PEG Ratio
Price to Book value
Price to Sales
Price to Cash Flow -10.84

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.